Schizophrenia and medication adherence: Associated factors

dc.authoridUSLU, ESRA/0000-0003-0168-2747
dc.contributor.authorKarabulut, Buse
dc.contributor.authorUslu, Esra
dc.date.accessioned2025-02-24T17:18:43Z
dc.date.available2025-02-24T17:18:43Z
dc.date.issued2024
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü
dc.description.abstractBackground: Schizophrenia is a chronic condition that requiring maintenance treatment with antipsychotic medication. Medication adherence is essential to improve the symptoms of this health problem reduce relapses and readmissions and achieve treatment goals. The rate of challenges associated with medication adherence in schizophrenia is reported to be 26.5-85.1 %. Purpose: This study was conducted to determine factors associated with medication adherence in individuals diagnosed with schizophrenia. Methods: A descriptive correlational research design was used. The study was completed with a total of 162 participants diagnosed with schizophrenia, between February-June 2021, at a Community Mental Health Center. Regression analysis (Model: enter and stepwise) was used to determine associated factors. Results: The mean medication adherence score of individual diagnosed with schizophrenia indicated that more than half of the participants (52 %) had poor medication adherence. In individual diagnosed with schizophrenia, medication attitudes, level of internalized stigma, the status of regular attendance to appointments, belief in recovery, and using medicines as prescribed were complicating factors for medication adherence (p < 0.05). Conclusions: Medication adherence in individuals with diagnosed schizophrenia may be multifactorial. Mental health professionals should consider associated factors and implement a personalized treatment plan in this direction for strengthening adherence to medication treatment.
dc.identifier.doi10.1016/j.apnu.2024.01.015
dc.identifier.endpage54
dc.identifier.issn0883-9417
dc.identifier.issn1532-8228
dc.identifier.pmid38734454
dc.identifier.scopusqualityQ2
dc.identifier.startpage47
dc.identifier.urihttps://doi.org/10.1016/j.apnu.2024.01.015
dc.identifier.urihttps://hdl.handle.net/20.500.14440/824
dc.identifier.volume49
dc.identifier.wosWOS:001179898000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofArchives of Psychiatric Nursing
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250201
dc.subjectMedication adherence
dc.subjectSchizophrenia
dc.subjectMental health professional
dc.titleSchizophrenia and medication adherence: Associated factors
dc.typeArticle

Dosyalar